[1]CurrentPatentAssignee:PFIZERINC-US2012/323010,2012,A1
[2]Wang,Tao;Du,Liang-Dong;Wan,Ding-Jian;Li,Xiang;Chen,Xin-Zhi;Wu,Guo-Feng[OrganicProcessResearchandDevelopment,2018,vol.22,#3,p.267-272]
[1]Patent:US2012/323010,2012,A1
[2]Patent:US2012/323010,2012,A1
[3]Patent:US2012/323010,2012,A1
[4]Patent:US2012/323010,2012,A1
[1]OrganicProcessResearchandDevelopment,2016,vol.20,p.1799-1805
[1]Patent:CN107417686,2017,A.Locationinpatent:Paragraph0036;0041
Title: Ehmann DE, et al. Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor. Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11663-8.
Title: Livermore DM, et al. Characterization of β-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104). J Antimicrob Chemother. 2012 Jun;67(6):1354-8.
Title: Berkhout J, et al. Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice. Antimicrob Agents Chemother. 2015 Apr;59(4):2299-304.
Title: Zhang W, et al. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae. Antimicrob Resist Infect Control. 2018 Nov 21;7:142.
